Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Reduction to Reach Elimination of Trachoma
NCT04185402Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in trachoma, sponsored by University of California, San Francisco. Started May 2021; status: completed.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT04185402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04185402.